Federated Investors Inc. PA cut its position in Insulet Corporation (NASDAQ:PODD) by 8.9% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 210,800 shares of the medical instruments supplier’s stock after selling 20,500 shares during the period. Federated Investors Inc. PA owned approximately 0.36% of Insulet Corporation worth $10,816,000 as of its most recent SEC filing.

Other hedge funds also recently bought and sold shares of the company. Strs Ohio raised its stake in Insulet Corporation by 73.9% in the first quarter. Strs Ohio now owns 4,000 shares of the medical instruments supplier’s stock worth $172,000 after buying an additional 1,700 shares during the period. SG Americas Securities LLC bought a new stake in Insulet Corporation during the second quarter worth about $180,000. Teacher Retirement System of Texas bought a new stake in Insulet Corporation during the first quarter worth about $201,000. Diversified Trust Co bought a new stake in Insulet Corporation during the second quarter worth about $205,000. Finally, Ameritas Investment Partners Inc. bought a new stake in Insulet Corporation during the first quarter worth about $215,000.

Shares of Insulet Corporation (NASDAQ PODD) opened at 57.71 on Tuesday. Insulet Corporation has a 52 week low of $30.69 and a 52 week high of $58.48. The stock has a 50 day moving average of $52.72 and a 200 day moving average of $46.15. The firm’s market cap is $3.35 billion.

Insulet Corporation (NASDAQ:PODD) last issued its quarterly earnings results on Thursday, August 3rd. The medical instruments supplier reported ($0.13) EPS for the quarter, hitting the Zacks’ consensus estimate of ($0.13). The business had revenue of $110 million for the quarter, compared to analyst estimates of $106.23 million. Insulet Corporation had a negative return on equity of 46.74% and a negative net margin of 7.30%. Insulet Corporation’s quarterly revenue was up 26.0% compared to the same quarter last year. During the same period last year, the company posted ($0.08) earnings per share. Equities analysts forecast that Insulet Corporation will post ($0.50) earnings per share for the current year.

TRADEMARK VIOLATION WARNING: “Insulet Corporation (PODD) Shares Sold by Federated Investors Inc. PA” was posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this story on another domain, it was illegally stolen and republished in violation of US & international copyright & trademark laws. The legal version of this story can be read at https://www.thecerbatgem.com/2017/08/29/insulet-corporation-podd-shares-sold-by-federated-investors-inc-pa.html.

PODD has been the subject of a number of research analyst reports. Northland Securities reissued a “buy” rating and issued a $50.00 price target on shares of Insulet Corporation in a research report on Tuesday, May 9th. Jefferies Group LLC cut their price objective on shares of Insulet Corporation from $53.00 to $48.00 and set a “buy” rating on the stock in a research report on Wednesday, May 10th. BTIG Research raised shares of Insulet Corporation from a “neutral” rating to a “buy” rating and set a $47.00 price objective on the stock in a research report on Wednesday, May 10th. Cowen and Company reaffirmed a “buy” rating and set a $52.00 price objective on shares of Insulet Corporation in a research report on Friday, July 14th. Finally, Zacks Investment Research raised shares of Insulet Corporation from a “hold” rating to a “buy” rating and set a $57.00 price objective on the stock in a research report on Tuesday, July 18th. Eight investment analysts have rated the stock with a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average price target of $50.46.

About Insulet Corporation

Insulet Corporation is engaged in the development, manufacturing and sale of the OmniPod Insulin Management System (the OmniPod System), an insulin delivery system for people with insulin-dependent diabetes. The Omnipod System features a self-adhesive disposable tubeless Omnipod device, which is worn on the body for approximately three days at a time and its wireless companion, the handheld Personal Diabetes Manager (PDM).

Institutional Ownership by Quarter for Insulet Corporation (NASDAQ:PODD)

Receive News & Stock Ratings for Insulet Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Insulet Corporation and related stocks with our FREE daily email newsletter.